Additionally, it has influenced key metabolic regulators, including gastrointestinal hormones (e.g., GLP-1, PYY) and hepatokines (e.g., fetuin-A, selenoprotein P), in individuals with hepatic steatosis [11]. Here, PYY is linked to fatty liver disease.